Prior to his appointment, Antonio was Bayer’s Head of Region Eastern Europe/Middle East (EMA)* within Pharmaceuticals Europe, Middle East & Africa. He brings a wealth of experience in strategy, change management, commercialisation, general management and sustainability.

Antonio started his studies in Biotechnology at Technische Universität (TU) Berlin, then transferred to Stanford University, California, where he obtained his B.S. in Chemical Engineering.  He attended graduate school at the University of Colorado at Boulder, where he received a M.S. in Chemical Engineering with a focus in Biotechnology.  He returned to TU Berlin to finalize his studies with a Ph.D. in Industrial Chemistry.

Antonio joined Bayer in 1996 as a Management Trainee in the Strategic Business Unit Diagnostics with Schering AG in Berlin. Then followed local, regional and global roles in Peru, Mexico and the USA, mostly in Specialty Therapeutics. He moved to Spain as Head of Business Unit (BU) Oncology and Oncology Hub Iberia in 2006. Following Bayer’s merger with Schering in the same year, Antonio was assigned to merge the two companies’ Oncology businesses and took over the joint leadership of the BU Oncology. This responsibility was extended to leading the entire hospital product portfolio as Head of BU Specialty, before he became Head of BU General Medicine in Spain in 2009.

In 2011 he took over as Country Division Head Pharmaceuticals and General Manager, Czech Republic & Slovakia, reorganising both countries into a country group. He moved to Bayer’s Headquarter in Leverkusen, Germany, in 2013 to lead Regional Coordination Europe. He returned to Pharmaceuticals in 2015 to lead a global project to develop the division’s go-to-market model.

He became Head of Region Eastern Europe/Middle East and Head of Global Healthcare Programs in2016, until the latter role transferred into the Sustainability Department in 2018.

*Turkey, Ukraine, North and Central Africa and Middle East